NasdaqGM - Delayed Quote USD
CRISPR Therapeutics AG (CRSP)
41.86
+3.29
+(8.53%)
At close: June 6 at 4:00:01 PM EDT
41.78
-0.08
(-0.19%)
After hours: June 6 at 7:59:43 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 153,248 | 14 |
| Sales | 93,413 | 13 |
| Net Shares Purchased (Sold) | 59,835 | 27 |
| Total Insider Shares Held | 1.52M | -- |
| % Net Shares Purchased (Sold) | 4.10% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| PATEL NAIMISH M.D. Officer | Sale at price 35.94 per share. | Direct | 141,316 | May 29, 2025 |
| PATEL NAIMISH M.D. Officer | -- | Direct | -- | May 28, 2025 |
| KULKARNI SAMARTH Chief Executive Officer | Sale at price 41.23 per share. | Direct | 413,578 | Mar 21, 2025 |
| KASINGER JAMES R. General Counsel | Sale at price 41.23 per share. | Direct | 131,318 | Mar 21, 2025 |
| PRASAD RAJU Chief Financial Officer | Sale at price 41.23 per share. | Direct | 90,582 | Mar 21, 2025 |
| BRUNO JULIANNE Chief Operating Officer | Sale at price 41.23 per share. | Direct | 70,668 | Mar 21, 2025 |
| BRUNO JULIANNE Chief Operating Officer | -- | Direct | -- | Mar 20, 2025 |
| KULKARNI SAMARTH Chief Executive Officer | -- | Direct | -- | Mar 20, 2025 |
| KASINGER JAMES R. General Counsel | -- | Direct | -- | Mar 20, 2025 |
| PRASAD RAJU Chief Financial Officer | -- | Direct | -- | Mar 20, 2025 |
| PRASAD RAJU Chief Financial Officer | Sale at price 41.80 per share. | Direct | 157,252 | Mar 17, 2025 |
| PRASAD RAJU Chief Financial Officer | -- | Direct | -- | Mar 14, 2025 |
| KULKARNI SAMARTH Chief Executive Officer | Sale at price 42.42 - 43.32 per share. | Direct | 616,348 | Mar 12, 2025 |
| KASINGER JAMES R. General Counsel | Sale at price 42.42 - 43.32 per share. | Direct | 169,242 | Mar 12, 2025 |
| BRUNO JULIANNE Chief Operating Officer | Sale at price 42.42 - 43.32 per share. | Direct | 59,050 | Mar 12, 2025 |
| KULKARNI SAMARTH Chief Executive Officer | -- | Direct | -- | Mar 11, 2025 |
| KASINGER JAMES R. General Counsel | -- | Direct | -- | Mar 11, 2025 |
| BRUNO JULIANNE Chief Operating Officer | -- | Direct | -- | Mar 11, 2025 |
| GREENE JOHN THOMAS Director | Purchase at price 44.85 per share. | Direct | 313,948 | Feb 26, 2025 |
| KULKARNI SAMARTH Chief Executive Officer | Sale at price 52.80 - 55.05 per share. | Direct | 1,006,580 | Feb 19, 2025 |
| KULKARNI SAMARTH Chief Executive Officer | Sale at price 55.20 per share. | Direct | 1,013,564 | Feb 19, 2025 |
| KASINGER JAMES R. General Counsel | Sale at price 52.80 - 53.85 per share. | Direct | 619,492 | Feb 19, 2025 |
| BRUNO JULIANNE Chief Operating Officer | Sale at price 52.80 per share. | Direct | 17,582 | Feb 19, 2025 |
| KULKARNI SAMARTH Chief Executive Officer | -- | Direct | -- | Feb 18, 2025 |
| KASINGER JAMES R. General Counsel | -- | Direct | -- | Feb 18, 2025 |
| BRUNO JULIANNE Chief Operating Officer | -- | Direct | -- | Feb 18, 2025 |
| KULKARNI SAMARTH Chief Executive Officer | Conversion of Exercise of derivative security at price 16.21 per share. | Direct | 222,904 | Dec 24, 2024 |
| KULKARNI SAMARTH Chief Executive Officer | Sale at price 55.10 per share. | Direct | 826,564 | Dec 2, 2024 |
| KULKARNI SAMARTH Chief Executive Officer | Sale at price 55.43 - 56.27 per share. | Direct | 1,668,678 | Nov 11, 2024 |
| KULKARNI SAMARTH Chief Executive Officer | Sale at price 46.28 per share. | Direct | 198,680 | Oct 14, 2024 |
| KASINGER JAMES R. General Counsel | Sale at price 46.28 per share. | Direct | 50,399 | Oct 14, 2024 |
| KULKARNI SAMARTH Chief Executive Officer | -- | Direct | -- | Oct 11, 2024 |
| KASINGER JAMES R. General Counsel | -- | Direct | -- | Oct 11, 2024 |
| KULKARNI SAMARTH Chief Executive Officer | Stock Gift at price 0.00 per share. | Direct | 0 | Aug 8, 2024 |
| BRUNO JULIANNE Chief Operating Officer | Sale at price 56.09 per share. | Direct | 188,799 | Jun 21, 2024 |
| BRUNO JULIANNE Chief Operating Officer | -- | Direct | -- | Jun 20, 2024 |
| KULKARNI SAMARTH Chief Executive Officer | Conversion of Exercise of derivative security at price 19.12 per share. | Direct | 374,408 | Apr 15, 2024 |
| KULKARNI SAMARTH Chief Executive Officer | Sale at price 59.88 - 60.40 per share. | Direct | 1,173,232 | Apr 15, 2024 |
| KULKARNI SAMARTH Chief Executive Officer | Conversion of Exercise of derivative security at price 19.12 per share. | Direct | 382,400 | Mar 15, 2024 |
| KULKARNI SAMARTH Chief Executive Officer | Sale at price 71.97 - 73.06 per share. | Direct | 1,449,628 | Mar 15, 2024 |
| PRASAD RAJU Chief Financial Officer | Sale at price 72.69 per share. | Direct | 256,160 | Mar 15, 2024 |
| PRASAD RAJU Chief Financial Officer | -- | Direct | -- | Mar 14, 2024 |
| KULKARNI SAMARTH Chief Executive Officer | Sale at price 74.44 - 78.26 per share. | Direct | 1,108,263 | Mar 12, 2024 |
| KASINGER JAMES R. General Counsel | Sale at price 74.44 - 78.26 per share. | Direct | 304,514 | Mar 12, 2024 |
| KULKARNI SAMARTH Chief Executive Officer | -- | Direct | -- | Mar 11, 2024 |
| KASINGER JAMES R. General Counsel | -- | Direct | -- | Mar 11, 2024 |
| GEORGE SIMEON J. Director | Stock Award(Grant) at price 71.50 per share. | Indirect | 74,999,996 | Feb 27, 2024 |
| KULKARNI SAMARTH Chief Executive Officer | Sale at price 79.67 per share. | Direct | 507,498 | Feb 20, 2024 |
| KASINGER JAMES R. General Counsel | Sale at price 79.67 per share. | Direct | 152,409 | Feb 20, 2024 |
| KULKARNI SAMARTH Chief Executive Officer | -- | Direct | -- | Feb 16, 2024 |
Related Tickers
NTLA Intellia Therapeutics, Inc.
8.09
+6.73%
BEAM Beam Therapeutics Inc.
18.58
+9.26%
RXRX Recursion Pharmaceuticals, Inc.
5.49
+20.13%
VRTX Vertex Pharmaceuticals Incorporated
450.50
+1.51%
REGN Regeneron Pharmaceuticals, Inc.
493.22
+2.10%
MRNA Moderna, Inc.
27.46
+5.13%
EDIT Editas Medicine, Inc.
1.9100
+6.11%
BNTX BioNTech SE
108.49
-1.51%
VKTX Viking Therapeutics, Inc.
27.83
+2.92%
SMMT Summit Therapeutics Inc.
20.59
+4.36%